Clinical Trial Update: A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 pilot trial is evaluating triheptanoin for preventive treatment of migraine, sponsored by the University of Liege; the study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: University of Liege | Conditions: Migraine | EARLY_Phase 1 | Status: UNKNOWN